Blog

by Vineti | March 26, 2021
As the creator of the leading digital platform for orchestrating cell and gene therapies, Vineti knows the operational hurdles faced by advanced therapy clinical trial teams. Here is an overview of some of the key challenges in cell and gene therapy…

by Amy DuRoss | March 25, 2021
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) — A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new and updated standards for advanced therapies. The new collaboration, which…

by Amy DuRoss | January 11, 2021
SAN FRANCISCO, January 11, 2020 (Globe Newswire) — Vineti, the leading provider of a digital platform of record for personalized therapeutics, today announced a new suite of flexibility features for its Personalized Therapy Management® (PTM)…

by Amy DuRoss | January 4, 2021
For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One of the ways we’ve been able to do that is through our Alliance Network, launched earlier in the year to provide an…

by Stuart Altman | December 15, 2020
In advanced therapies, little labels -- the in-process labels on bags of cells and final drug products -- can sometimes add up to big problems. Vineti’s expanded, flexible PTM® Label Printing changes that.

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required